Cheryl L Cox1, Liang Zhu2, Sue C Kaste1,3, Kumar Srivastava1, Linda Barnes1, Paul C Nathan4, Robert J Wells5, Kirsten K Ness1. 1. Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee. 2. Department of Biostatistics, The University of Texas Health Science Center at Houston, Houston, Texas. 3. Department of Radiology, The University of Tennessee Health Science Center, Memphis, Tennessee. 4. The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. 5. Division of Pediatrics-Unit 87, MD Anderson Cancer Center, Houston, Texas.
Abstract
BACKGROUND: The early effects of childhood acute lymphoblastic leukemia (ALL) include decreased physical function, bone mineral density (BMD/g/cm2 ), and health-related quality of life (HRQL). We assessed the capacity of a physical therapy and motivation-based intervention, beginning after diagnosis and continuing through the end of treatment, to positively modify these factors. PROCEDURE: A 2.5-year randomized controlled trial of 73 patients aged 4-18.99 years within 10 days of ALL diagnosis assessed BMD at baseline (T0 ) and end of therapy (T3 ), strength, range of motion, endurance, motor skills, and HRQL at baseline (T0 ), 8 (T1 ), 15 (T2 ), and 135 (T3 ) weeks. RESULTS: There were no significant changes between groups (intervention, n = 33; usual care, n = 40) in BMD (P = 0.059) at T3 or physical function and HRQL at T0 -T3 . While BMD declined in both the intervention (T0 = -0.21, T3 = -0.55) and usual care (T0 = -0.62, T3 = -0.78) groups, rates of decline did not differ between groups (P = 0.56). Univariate analysis (n = 73) showed associations of higher T3 bone density with body mass index T1 (P = 0.01), T2 (P = <0.0001), T3 (P = 0.01), T3 ankle flexibility/strength (P = 0.001), and T2 parent (P = 0.02)/T0 child (P = 0.03) perceptions of less bodily pain. CONCLUSIONS: The intervention delivered during treatment was not successful in modifying BMD, physical function, or HRQL. Physical activity, at the level and intensity required to modify these factors, may not be feasible during early treatment owing to the child's responses to the disease and treatment. Future studies will consider intervention implementation during late maintenance therapy, extending into survivorship.
RCT Entities:
BACKGROUND: The early effects of childhood acute lymphoblastic leukemia (ALL) include decreased physical function, bone mineral density (BMD/g/cm2 ), and health-related quality of life (HRQL). We assessed the capacity of a physical therapy and motivation-based intervention, beginning after diagnosis and continuing through the end of treatment, to positively modify these factors. PROCEDURE: A 2.5-year randomized controlled trial of 73 patients aged 4-18.99 years within 10 days of ALL diagnosis assessed BMD at baseline (T0 ) and end of therapy (T3 ), strength, range of motion, endurance, motor skills, and HRQL at baseline (T0 ), 8 (T1 ), 15 (T2 ), and 135 (T3 ) weeks. RESULTS: There were no significant changes between groups (intervention, n = 33; usual care, n = 40) in BMD (P = 0.059) at T3 or physical function and HRQL at T0 -T3 . While BMD declined in both the intervention (T0 = -0.21, T3 = -0.55) and usual care (T0 = -0.62, T3 = -0.78) groups, rates of decline did not differ between groups (P = 0.56). Univariate analysis (n = 73) showed associations of higher T3 bone density with body mass index T1 (P = 0.01), T2 (P = <0.0001), T3 (P = 0.01), T3 ankle flexibility/strength (P = 0.001), and T2 parent (P = 0.02)/T0 child (P = 0.03) perceptions of less bodily pain. CONCLUSIONS: The intervention delivered during treatment was not successful in modifying BMD, physical function, or HRQL. Physical activity, at the level and intensity required to modify these factors, may not be feasible during early treatment owing to the child's responses to the disease and treatment. Future studies will consider intervention implementation during late maintenance therapy, extending into survivorship.
Authors: Ralf Geiger; Alexander Strasak; Benedikt Treml; Klaus Gasser; Axel Kleinsasser; Victoria Fischer; Harald Geiger; Alexander Loeckinger; Joerg I Stein Journal: J Pediatr Date: 2007-04 Impact factor: 4.406
Authors: Geoffrey C Williams; Holly A McGregor; Daryl Sharp; Chantal Levesque; Ruth W Kouides; Richard M Ryan; Edward L Deci Journal: Health Psychol Date: 2006-01 Impact factor: 4.267
Authors: Christopher Lethaby; John Wiernikowski; Alessandra Sala; Marissa Naronha; Colin Webber; Ronald D Barr Journal: J Pediatr Hematol Oncol Date: 2007-09 Impact factor: 1.289
Authors: C H Pui; D Pei; D Campana; C Cheng; J T Sandlund; W P Bowman; M M Hudson; R C Ribeiro; S C Raimondi; S Jeha; S C Howard; D Bhojwani; H Inaba; J E Rubnitz; M L Metzger; T A Gruber; E Coustan-Smith; J R Downing; W H Leung; M V Relling; W E Evans Journal: Leukemia Date: 2014-04-30 Impact factor: 11.528
Authors: Gabriel M Pagnotti; Maya Styner; Gunes Uzer; Vihitaben S Patel; Laura E Wright; Kirsten K Ness; Theresa A Guise; Janet Rubin; Clinton T Rubin Journal: Nat Rev Endocrinol Date: 2019-06 Impact factor: 43.330
Authors: Mary C Hooke; Michelle A Mathiason; Audrey Blommer; Jessica Hutter; Pauline Mitby; Olga Taylor; Michael E Scheurer; Alicia S Kunin-Batson; Wei Pan; Marilyn J Hockenberry Journal: Cancer Nurs Date: 2022 Mar-Apr 01 Impact factor: 2.592
Authors: Emma Jacobine Verwaaijen; Annelienke van Hulst; Marta Fiocco; Annelies Hartman; Martha Grootenhuis; Saskia Pluijm; Rob Pieters; Erica van den Akker; Marry M van den Heuvel-Eibrink Journal: JMIR Res Protoc Date: 2022-04-11
Authors: Carolina Simioni; Giorgio Zauli; Alberto M Martelli; Marco Vitale; Simona Ultimo; Daniela Milani; Luca M Neri Journal: Oncotarget Date: 2018-03-30
Authors: Martin Kaj Fridh Nielsen; Jesper Frank Christensen; Thomas Leth Frandsen; Troels Thorsteinsson; Lars Bo Andersen; Karl Bang Christensen; Peder Skov Wehner; Henrik Hasle; Lis Ørgaard Adamsen; Kjeld Schmiegelow; Hanne Bækgaard Larsen Journal: BMC Med Date: 2020-07-06 Impact factor: 8.775
Authors: Javier S Morales; Pedro L Valenzuela; Daniel Velázquez-Díaz; Adrián Castillo-García; David Jiménez-Pavón; Alejandro Lucia; Carmen Fiuza-Luces Journal: Cancers (Basel) Date: 2021-12-24 Impact factor: 6.639
Authors: Paula A Ospina; Alyssa McComb; Lesley E Pritchard-Wiart; David D Eisenstat; Margaret L McNeely Journal: Cochrane Database Syst Rev Date: 2021-08-03